Acclinate Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 62

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.5M

  • Investors
  • 25

Acclinate General Information

Description

Developer of a digital health platform designed to facilitate an increase in representation and diversity of their genomic research and clinical trials. The company's platform utilizes machine learning and predictive analytics to automate the identification, education, engagement, and retention of willing and diverse genomic research and clinical trial participants, enabling biopharmaceutical research organizations to decrease the overall cost of drug development.

Contact Information

Formerly Known As
Acclinate Genetics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1143 1st Avenue South
  • Suite 114
  • Birmingham, AL 35233
  • United States
+1 (256)
Primary Industry
Other Healthcare Technology Systems
Corporate Office
  • 1143 1st Avenue South
  • Suite 114
  • Birmingham, AL 35233
  • United States
+1 (256)

Acclinate Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acclinate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 27-Feb-2026 $3.5M Completed Generating Revenue
7. Early Stage VC (Series A) 07-May-2024 Completed Generating Revenue
6. Seed Round 19-Oct-2022 Completed Generating Revenue
5. Accelerator/Incubator 11-Oct-2022 Completed Generating Revenue
4. Accelerator/Incubator 17-Aug-2021 Completed Generating Revenue
3. Accelerator/Incubator 27-Jan-2021 Completed Generating Revenue
2. Grant 27-Feb-2020 $50K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Acclinate’s complete valuation and funding history, request access »

Acclinate Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-3
Seed-2 355,217 $0.000010 $3.03 $3.03 1x $3.03 9.59%
Seed-1 256,452 $0.000010 $1.51 $1.51 1x $1.51 6.93%
To view Acclinate’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Acclinate Patents

Acclinate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12170131-B2 System for determining clinical trial participation Active 25-May-2022
US-12770112-B2 System for determining clinical trial participation Active 25-May-2022
US-20230386619-A1 System for determining clinical trial participation Active 25-May-2022
US-20260141992-A1 System for determining clinical trial participation Active 25-May-2022 G06Q10/40

Acclinate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acclinate Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate Alabama Corporation Minority
Cencora Ventures Corporate Venture Capital Minority
Cerity Partners Ventures Corporate Venture Capital Minority
Gaingels Venture Capital Minority
Labcorp Venture Fund Corporate Venture Capital Minority
You’re viewing 5 of 25 investors. Get the full list »

Acclinate FAQs

  • When was Acclinate founded?

    Acclinate was founded in 2020.

  • Where is Acclinate headquartered?

    Acclinate is headquartered in Birmingham, AL.

  • What is the size of Acclinate?

    Acclinate has 62 total employees.

  • What industry is Acclinate in?

    Acclinate’s primary industry is Other Healthcare Technology Systems.

  • Is Acclinate a private or public company?

    Acclinate is a Private company.

  • What is Acclinate’s current revenue?

    The current revenue for Acclinate is .

  • How much funding has Acclinate raised over time?

    Acclinate has raised $15.6M.

  • Who are Acclinate’s investors?

    Innovate Alabama, Cencora Ventures, Cerity Partners Ventures, Gaingels, and Labcorp Venture Fund are 5 of 25 investors who have invested in Acclinate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process